ICRF logo

ICRF President’s Message | ICRF Chair’s Message | International Board of Trustees


ICRF President’s Message

Rob Densen

Dear Friends:

Thank you for your interest in – and support of – the Israel Cancer Research Fund (ICRF). We are the largest non-profit in North America dedicated to funding Israeli cancer research.

I hope this finds you happy, healthy, and safe in these challenging times.

COVID-19 notwithstanding, Israel continues at the cutting edge of global cancer research. That’s why I am so proud to report that we will be funding new research at near-record levels over the next 12 months.

As you review this site, I hope you’ll take the time to check out our “Brilliant Minds” Webinar Series as well as the interview with Nobel Prize winner Aaron Ciechanover included in our Virtual Gala video. You will discover that Israel is a major source of innovation in the understanding and treatment of cancer and that many of Israel’s most promising cancer research investigations have been funded by ICRF.

To me, the case for support of ICRF is clear-cut and compelling. Israeli cancer research is world-class and – due to lower overhead costs and ICRF’s ability to directly fund its grantees – very cost-effective. Or as my financial services friends might put it, with ICRF you get both growth and value.

Know, too, that even as we push smartly and energetically forward towards the cures we all hope for, ICRF is funding important advances that are benefitting millions of families now. From Velcade® to Doxil® to Gleevec®, ICRF scientists have made essential contributions to the development of many groundbreaking drugs, giving millions of families, including mine, the greatest gift of all – more time together.

Unfortunately, every year, ICRF receives more promising research proposals than we have dollars to fund. Our goal: to make sure that no deserving cancer research project in Israel goes unfunded. Ever. With your help, we can make that happen.

A prominent Israeli cancer researcher was once asked, “When will there be a cure for cancer?” His response: “No money, never. Some money, one day. More money, sooner.”

As I write this, we are entering the holiday season – both secular and religious. I hope at this time of gratitude, hope and charity, you will consider a generous donation to this worthy cause and well-respected organization.

Sincerely,

Rob Densen
President, ICRF International


ICRF Chair’s Message

Dear Friends:

ICRF was founded 45 years ago by a group of American physicians and scientists to provide funding for cancer research in Israel. Our mission is to further advance our understanding of cancer and facilitate discoveries that might lead to effective treatments. While the initial focus of our founders was to prevent the “brain drain” of talented and brilliant Israeli researchers leaving the country due to lack of financial support, their ultimate dream is still our dream today – that a cure for cancer will be discovered in Israel – and benefit all humankind.

To date, ICRF has transferred over $77.5 million, which has funded over 2,500 grants conducted by Israeli scientists at 22 different Israeli research labs. This accomplishment is a credit to the successful combination of generous donors, outstanding scientists, enthusiastic volunteers, and devoted staff – all are essential to the achievement of our mission.

Cancer scientists in Israel are invited to submit their grant proposals to ICRF which are then rigorously reviewed and graded by a scientific review board to ensure that the best and most promising grant proposals are identified. Each year, renowned scientists and highly esteemed oncologists gather in New York to review these scientific grant applications from Israeli scientists. And each year, there are more superb grant proposals worthy of funding than dollars available to support them.

And so our challenge is to raise as much money as possible through our chapters (6 in the U.S., 2 in Canada and 1 in Israel) to support the groundbreaking work of Israeli cancer scientists. By doing so we accomplish two worthy goals – first, contributing to top notch research aimed at discovering the keys to combating cancer and developing effective cures, and second, supporting Israel by helping to fund its best scientists.

Over the past decade, I had the privilege of participating in three scientific missions to Israel with ICRF supporters. At research labs across Israel we heard first hand from Israeli scientists about the advances they were making and the pressing need for more funds to support their research. These missions strengthened my personal connection to ICRF and inspired me to help elevate our brand and increase awareness of and support for the invaluable work done by cancer scientists in Israel.

I am proud and honored to serve as Chair of ICRF International. I hope to build on the achievements of my predecessors with the goal of funding as many outstanding Israeli scientists as possible in their quest to increase cancer understanding leading to effective treatments.

Thanks to those of you who have contributed to ICRF – you can be proud that you have become a valuable stakeholder in working towards a cure for cancer. For those who are new to ICRF, we look forward to engaging with you on our journey to support cancer research in Israel.

Sincerely,

Bryna Goldberg
Chair, ICRF International


International Board of Trustees 2020

President

Rob Densen

Chair

Bryna Goldberg

First Vice-President

Joel Pelofsky

Vice-Chairman

Peter J. Stambrook, PhD*

Vice Presidents

David Abramson
Charles Ben Dayan
Jeffrey Bernstein

Treasurer

Alan Berk

Secretary

Cynthia Perl

Executive Committee Members

Arnold Baskies, MD
Benjamin Bonavida, PhD
Vera Finkelstein
Brad Goldhar
Yashar Hirshaut, MD

Trustees

Robert Bard
Bruce Barron
Jeffrey Bly
Louis Brause
Michelle Chrein
Steven B. Cohen
Bonnie E. Fish
Paul T. Fox
Donald Friedman♦
Tamir Gilat
Kenneth E. Goodman
Gary I. Grad, MD
Robert Greene
Maryanne Greenfield
Samuel Herzfeld
Clive Kabatznik
Ian Kady
Barbara Kasell
Susan Matteson King
Richard Lipkin
Moni Lustig
David Malkin, MD
Patrick Mundt
Linnea Olson
Lisa Oved
Tom Peled
Jane Rabhan
Sarah Rosen
Lisa Schoenberg
Sidney J. Winawer, MD♦
Dov Zevy

Presidents Emeritus

Harriet Elisofon
Brad Goldhar
Yashar Hirshaut, MD
Harvey Kaylie*
Daniel G. Miller, MD*
Theodore T. Miller, MD

Chairpersons Emeritus

Donald Friedman♦
Kenneth E. Goodman
Yashar Hirshaut, MD
Michael Rosenfelt
Leah Susskind*
Eve Wald

Honorary Board Members

Evelyn Bienenfeld
Benjamin Brafman
Lynda Brafman
Harriet Elisofon
Maralyn Friedman
Faith G. Miller
Steven T. Rosen, MD
Michael Rosenfelt
Judith Sherman
Michel Steinberger
Eve Wald

National Executive Director

Mark A. Israel, MD


* Deceased
♦ Charter Board Member 

View ICRF Chapters